Clinical trial
Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain…
NCT00441259 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00441259 |
|---|---|
| Title | Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age |
| Official title | Randomised, Double Blind, Controlled, Safety, Tolerability and Immunogenicity Phase II Trial of ChimeriVax™-JE and Japanese Encephalitis Inactivated Mouse Brain Vaccine in Children of Descending Age. |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Japanese Encephalitis |
| Intervention type | Biological |
| Interventions | ChimeriVax™-JE, Japanese Encephalitis Inactivated Mouse Brain Vaccine |
| Enrollment | 96 |
| Start date | Jan 1, 2007 |
| Primary completion | Feb 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Feb 28, 2007 |
| Last update posted | Aug 27, 2012 |
| Countries | India |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: